Commit Lozenge ads
This article was originally published in The Tan Sheet
Executive Summary
TV spots for OTC smoking cessation lozenge airing now on major networks, GSK says. Designed by Arnold McGrath Worldwide, ads feature different angles of a lone cigarette against a simple background. "This thing you carry with you everywhere, this thing you obsess about and face ridicule for, this thing you're not sure you'll ever be able to quit, may have just met its match," a voiceover states, before detailing recommended use of Commit. TV spots will be complemented by 1Web site, newspaper ads in publications such as USA Today. Commit nicotine polacrilex lozenge debuted late last month, features "time to first cigarette" dosage selection tool (2"The Tan Sheet" Nov. 4, 2002, p. 3)...
You may also be interested in...
GSK Commit Lozenge Phase IV Studies On Contraindications, AEs Planned
GlaxoSmithKline's Phase IV obligations for its Commit nicotine polacrilex lozenge include a study of consumers who are contraindicated for use of the OTC smoking cessation drug due to underlying health conditions, FDA's Oct. 31 approval letter states
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.